Abstract
The effect of selective D-1 and D-2 dopamine agonists on catalepsy induced by various dopamine antagonists was studied. A potent and selective D-2 antagonist, YM-09151 (YM-09151-2) at a dose of 1.2 mg/kg, SC and a selective D-1 antagonist, SCH 23390 at 1.0 mg/kg, SC induced catalepsy in rats. Mixed D-1/D-2 antagonists, haloperidol (HPD) and cis-flupentixol (FLU) also induced catalepsy at doses of 2.0 and 0.8 mg/kg, SC, respectively. A mixed D-1/D-2 agonist, apomorphine (1.0 mg/kg, SC), a selective D-2 agonist, bromocriptine (10 mg/kg, IP) and a muscarinic antagonist, scopolamine (1.0 mg/kg, SC), prevented or markedly reduced the incidence of catalepsy by the tested antagonists. In contrast, a selective D-1 agonist, SKF 38393 (4.0 mg/kg, SC) did not reduce the cataleptogenic effects of HPD, FLU and SCH 23390, but did reduce the effect of YM-09151. Moreover, co-administration of YM-09151 with SCH 23390 produced a marked increase in the incidence of catalepsy. The incidence seen after the combination of YM-09151 and SCH 23390 at low doses was significantly different from that seen after each drug alone at the doubled dose. Thus, D-1 and D-2 antagonists potentiated each other's effect in producing catalepsy. These results suggest an important role of both D-1 and D-2 receptors in the catalepsy and the existence of synergistic effects of D-1 and D-2 receptor blockade.
Similar content being viewed by others
References
Andersen PH, Nielsen EB, Scheel-Krüger J, Jansen JA, Hohlweg R (1987) Thienopyridine derivatives identified as the first selective, full efficacy dopamine D1 receptor agonists. Eur J Pharmacol 737:291–292
Arnt J, Hyttel J (1985) Differential involvement of dopamine D-1 and D-2 receptors in the circling behavior induced by apomorphine, SK&F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacology 85:346–352
Arnt J, Perregaard J (1987) Synergistic interaction between dopamine D-1 and D-2 receptor agonists: circling behavior of rats with hemitransection. Eur J Pharmacol 143:45–53
Arnt J, Hyttel J, Perregaard J (1987) Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur J Pharmacol 133:137–145
Braun AR, Chase TN (1986) Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131:301–306
Carlson JH, Bergstrom DA, Walters JR (1987) Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Brain Res 400:205–218
Christensen AV, Arnt J, Hyttel J, Larsen J-J, Svendsen O (1984) Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529–1540
Hyttel J (1984) Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390. Neuropharmacology 23:1395–1401
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Markstein R, Herrling PL, Burki HR, Asper H, Ruch W (1978) The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism. J Neurochem 31:1163–1172
Meller E, Kuga S, Friedhoff AJ, Goldstein M (1985) Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist. Life Sci 36:1857–1864
Morelli M, Di Chiara G (1985) Catalepsy induced by SCH 23390 in rats. Eur J Pharmacol 117:179–185
Nielsen EB, Andersen PH (1985) Behavioral evidence that SK&F 38393 is a partial agonist at dopamine receptors. Soc Neurosci Abstr 11:176
Robertson GS, Robertson HA (1986) Synergistic effects of D1 and D2 dopamine agonists on turning behavior in rats. Brain Res 384:387–390
Setler PE, Sarau HM, Zirkle CL, Sauders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50:419–430
Terai M, Usuda S, Kuroiwa I, Noshiro O, Maeno H (1983) Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors. Jpn J Pharmacol 33:749–755
Undie AS, Friedman E (1988) Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics. Psychopharmacology 96:311–316
Usuda S, Nishikori K, Noshiro O, Maeno H (1981) Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro2-methyoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity. Psychopharmacology 73:103–109
Weick BG, Walters JR (1987) Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Brain Res 405:234–246
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wanibuchi, F., Usuda, S. Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats. Psychopharmacology 102, 339–342 (1990). https://doi.org/10.1007/BF02244101
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244101